Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 17 beta-estradiol  (1)
  • ESOPHAGEAL MOTILITY  (1)
  • 1
    ISSN: 1432-1041
    Keywords: cimetidine ; ramixotidine ; prolactin ; testosterone ; 17 beta-estradiol ; H2-receptors ; CM 57755A ; gastrin ; healthy volunteers
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Three groups of eight healthy male volunteers received placebo for 2 days, then daily morning doses either of cimetidine 800 mg, ramixotidine 750 mg (CM 57755A), or placebo, for 14 days, and then were all returned to placebo for one more day. Plasma levels of prolactin, testosterone and 17β-estradiol were measured on Days 2, 3, 16 and 17 in blood samples taken 30 and 15 min before and 0, 60, 120, 180, 240 and 300 min after treatment. Gastrin was assayed in blood collected on the same days 180 min after treatment. Mean pre- and post-treatment areas under the time-concentration curves of the first three hormones were not significantly different in the three groups on any test day, or within the same group throughout the four test days. Mean plasma gastrin levels ranged between 27 and 42 pg/ml, respectively, in the placebo and cimetidine treated groups on test day 3, and intermediate values were found in the group receiving CM 57755A. There was no statistically significant difference in gastrin level between the groups on any test day or within the same group throughout the four test days. No subjective side-effects attributable to the treatments were reported, and there were no abnormalities in blood pressure, heart rate or standard laboratory tests.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Digestive diseases and sciences 44 (1999), S. 1716-1720 
    ISSN: 1573-2568
    Keywords: SYSTEMIC SCLEROSIS ; ESOPHAGEAL PH ; ESOPHAGEAL MOTILITY ; ESOPHAGEAL CLEARANCE
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Incidental clinical observations suggest thatbuffering substances may accumulate in the distalesophagus of patients with systemic sclerosis. The aimof our study was to assess if the buffering capacity of the intraesophageal milieu is increased inpatients with systemic sclerosis and if this effect canbe correlated to some pathophysiological aspects of thedisease. We recorded intraesophageal pH before and during a 10-min intraesophageal infusion ofacid (HCl 0.01 N, 1 ml/min), as well as esophagealmotility and clearance function, in 16 patients withsystemic sclerosis and 10 healthy subjects. Esophageal buffering capacity expressed as the area underthe curve of intraesophageal pH during acid infusion wassignificantly higher in the patients than in thecontrols, and this variable was directly correlated with esophageal clearing time. In conclusion,esophageal buffering capacity is increased in patientswith systemic sclerosis and is possibly the consequenceof the accumulation of buffering substances in the distal esophagus.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...